Deep Track Capital, LP Guardant Health, Inc. Transaction History
Deep Track Capital, LP
- $2.82 Billion
- Q2 2025
A detailed history of Deep Track Capital, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 4,250,000 shares of GH stock, worth $283 Million. This represents 7.85% of its overall portfolio holdings.
Number of Shares
4,250,000
Previous 5,443,721
21.93%
Holding current value
$283 Million
Previous $232 Million
4.63%
% of portfolio
7.85%
Previous 8.11%
Shares
9 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$809 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$747 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$331 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$320 Million0.2% of portfolio
-
Invesco Ltd. Atlanta, GA3.56MShares$237 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.8B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...